STAT3 and breast cancer: However, the data presented provide the first evidence that: 1) FRK is lost in breast cancer cells with mesenchymal phenotype ; 2) FRK expression correlates positively with epithelial markers and 3) the overexpression of FRK suppresses STAT3 activation leading to reduced STAT3 phosphorylation.